Maphe Mthembu

Maphe Mthembu

Auto-generated profile, based on publicly available information

Maphe Mthembu

Africa Health Research Institute

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2023 in EBioMedicine
Verified
Journal Article
Open access
MMMaphe Mthembu
Maphe Mthembu
KBKathryn A. Bowman
Kathryn A. Bowman
LDLeela R.L. Davies
Leela R.L. Davies
SKSharon Khuzwayo
Sharon Khuzwayo
LMLusanda Mazibuko
Lusanda Mazibuko
EWEmily B Wong
Emily B Wong
Tuberculosis (TB) is a leading infectious cause of death worldwide and treating latent TB infection (LTBI) with TB preventative therapy is a global priority. This study aimed to measure interferon gamma (IFN-γ) release assay (IGRA) positivity (the current reference standard for LTBI diagnosis) and Mtb-specific IgG antibodies in otherwise healthy adults without HIV and those living with HIV (PLWH). One-hundred and eighteen adults (65 without HIV and 53 antiretroviral-naïve PLWH), from a peri-urban setting in KwaZulu-Natal, South Africa were enrolled. IFN-γ released following stimulation with ESAT-6/CFP-10 peptides and plasma IgG antibodies specific for multiple Mtb antigens were measured using the QuantiFERON-TB Gold Plus (QFT) and customized Luminex assays, respectively. The relationships between QFT status, relative concentrations of anti-Mtb IgG, HIV-status, sex, age and CD4 count were analysed. Older age, male sex and higher CD4 count were independently associated with QFT positivity (p = 0.045, 0.05 and 0.002 respectively). There was no difference in QFT status between people with and without HIV infection (58% and 65% respectively, p = 0.06), but within CD4 count quartiles, people with HIV had higher QFT positivity than people without HIV (p = 0.008 (2nd quartile), <0.0001 (3rd quartile)). Concentrations of Mtb-specific IFN-γ were lowest, and relative concentrations of Mtb-specific IgGs were highest in PLWH in the lowest CD4 quartile. These results suggest that the QFT assay underestimates LTBI among immunosuppressed people with HIV and Mtb-specific IgG may be a useful alternative biomarker for Mtb infection. Further evaluation of how Mtb-specific antibodies can be leveraged to improve LTBI diagnosis is warranted, particularly in HIV-endemic areas. NIH, AHRI, SHIP: SA-MRC and SANTHE.

16 October 2024 in iScience
Verified
Journal Article
Open access
MMMaphe Mthembu
Maphe Mthembu
HCHelgard Claassen
Helgard Claassen
SKSharon Khuzwayo
Sharon Khuzwayo
VVValentin Voillet
Valentin Voillet
ANAnneta Naidoo
Anneta Naidoo
EWEmily B. Wong
Emily B. Wong
HIV causes susceptibility to respiratory pathogens, including tuberculosis (TB), but the underlying immunological mechanisms remain incompletely understood. We obtained whole blood and bronchoalveolar lavage (BAL) from TB-exposed people in the presence or absence of antiretroviral-naïve HIV co-infection. Bulk transcriptional profiling demonstrated compartment-specific enrichment of immunological processes. Systems-level deconvolution of whole blood from people living with HIV identified elevated type I and type II interferon cytokine activity and T cell proliferation. Transcriptional modules derived from both peripheral blood and sorted BAL immune cells demonstrated an increased frequency of effector memory CD8 T cells in whole BAL samples. Both compartments displayed reduced induction of CD8 T-cell-derived interleukin-17A (IL-17A) in people with HIV, associated with elevated T cell regulatory molecule expression. The data suggest that dysfunctional CD8 T cell responses in uncontrolled HIV may contribute to compromised respiratory immunity to pathogens, a process that could be modulated by host-directed therapies that target CD8 T cell effector functions.

20 November 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
SKSharon Khuzwayo
Sharon Khuzwayo
MMMaphe Mthembu
Maphe Mthembu
EMErin W. Meermeier
Erin W. Meermeier
SPSanjay M. Prakadan
Sanjay M. Prakadan
SKSamuel W. Kazer
Samuel W. Kazer
EWEmily B Wong
Emily B Wong
Mucosal associated invariant T (MAIT) cells are a class of innate-like T cells that utilize a semi-invariant αβ T cell receptor to recognize small molecule ligands produced by bacteria and fungi. Despite growing evidence that immune cells at mucosal surfaces are often phenotypically and functionally distinct from those in the peripheral circulation, knowledge about the characteristics of MAIT cells at the lung mucosal surface, the site of exposure to respiratory pathogens, is limited. HIV infection has been shown to have a profound effect on the number and function of MAIT cells in the peripheral blood, but its effect on lung mucosal MAIT cells is unknown. We examined the phenotypic, functional, and transcriptomic features of MR1 restricted MAIT cells from the peripheral blood and bronchoalveolar compartments of otherwise healthy individuals with latent Mycobacterium tuberculosis (Mtb) infection who were either HIV uninfected or HIV infected. Peripheral blood MAIT cells consistently co-expressed typical MAIT cell surface markers CD161 and CD26 in healthy individuals, while paired bronchoalveolar MAIT cells displayed heterogenous expression of these markers. Bronchoalveolar MAIT cells produced lower levels of pro-inflammatory cytokine IFN-γ and expressed higher levels of co-inhibitory markers PD-1 and TIM-3 than peripheral MAIT cells. HIV infection resulted in decreased frequencies and pro-inflammatory function of peripheral blood MAIT cells, while in the bronchoalveolar compartment MAIT cell frequency was decreased but phenotype and function were not significantly altered. Single-cell transcriptomic analysis demonstrated greater heterogeneity among bronchoalveolar compared to peripheral blood MAIT cells and suggested a distinct subset in the bronchoalveolar compartment. The transcriptional features of this bronchoalveolar subset were associated with atypical MAIT cells and tissue repair functions. In summary, we found previously undescribed phenotypic and transcriptional heterogeneity of bronchoalveolar MAIT cells in healthy people. In HIV infection, we found numeric depletion of MAIT cells in both anatomical compartments but preservation of the novel phenotypic and transcriptional features of bronchoalveolar MAIT cells.

5 May 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
MMMaphe Mthembu
Maphe Mthembu
HCHelgard Claassen
Helgard Claassen
SKSharon Khuzwayo
Sharon Khuzwayo
VVValentin Voillet
Valentin Voillet
ANAnneta Naidoo
Anneta Naidoo
EWEmily B Wong
Emily B Wong
Mechanisms by which HIV causes susceptibility to respiratory pathogens remain incompletely understood. We obtained whole blood and bronchoalveolar lavage (BAL) from people with latent TB infection in the presence or absence of antiretroviral-naïve HIV co-infection. Transcriptomic and flow cytometric analyses demonstrated HIV-associated cell proliferation plus type I interferon activity in blood and effector memory CD8 T-cells in BAL. Both compartments displayed reduced induction of CD8 T-cell-derived IL-17A in people with HIV, associated with elevated T-cell regulatory molecule expression. The data suggest that dysfunctional CD8 T-cell responses in uncontrolled HIV contribute to susceptibility to secondary bacterial infections, including tuberculosis.

11 September 2026 in medRxiv
Verified
Preprint
Open access
PDF file
MMMaphe Mthembu
Maphe Mthembu
KBKathy Baisley
Kathy Baisley
JBJacob Busang
Jacob Busang
NNNqobile Ngoma
Nqobile Ngoma
NNNdlela Nonsikelelo
Ndlela Nonsikelelo
MSMaryam Shahmanesh
Maryam Shahmanesh
Background Human papillomavirus (HPV) is the primary cause of cervical cancer, with women living with HIV at increased risk of HPV infection and HPV related disease. Data on HPV prevalence and genotype distribution among adolescent girls and young women (AGYW) in rural South African settings remain limited. We estimated HPV prevalence, genotype distribution, and factors associated with HPV infection among AGYW in a high HIV prevalence district of KwaZulu Natal, South Africa. Methods This cross-sectional study was nested within the baseline survey of the Thetha Nami population-based trial among young people aged 15 to 30 years in rural uMkhanyakude District, KwaZulu-Natal. Survey participants were asked to provide dried blood spots for HIV testing and genital swabs for STI testing. For this study, we selected AGYW living with HIV with available vaginal swabs and a frequency-matched sample of AGYW without HIV. HPV genotyping was done using the HPV Direct Flow Chip Kit (Master Diagnostica, Spain). Genotype-specific HPV prevalence was described overall and by HIV status. Logistic regression was used to identify factors associated with HPV infection. Results Among 187 AGYW with valid HPV results, 90 (48.1%) were living with HIV. Overall HPV prevalence was 69.1% (95% confidence interval (CI)=54.5 to 80.7%) and high-risk (hr)HPV prevalence was 57.3% (95%CI=44.1 to 69.6%). HPV prevalence was higher among AGYW living with HIV than among AGYW without HIV (84.6% vs 64.6%, p=0.02). HPV genotype distribution varied by HIV status: HPV35, HPV45 and HPV58 were the most prevalent hrHPV genotypes among AGYW living with HIV, vs HPV52, HPV56 and HPV31 among AGYW without HIV. No HPV16 or HPV18 infections were detected among participants who were age-eligible for the national HPV vaccination programme. Reported condomless sex (adjusted odds ratio (aOR)=2.23, 95%CI=1.06 to 4.70) and the presence of another sexually transmitted infection (aOR=4.30, 95%CI=1.52 to 12.20) were associated with HPV infection. Conclusions AGYW in rural uMkhanyakude experience a high burden of hrHPV infection, especially those living with HIV. Regardless of HPV vaccination status not being confirmed, no HPV 16/18 was detected among vaccine-eligible AGYW. The higher prevalence of non-HPV16/18 hrHPV genotypes covered by the nonavalent vaccine highlights the potential value of vaccines with broader genotype coverage. These findings support expanding HPV screening and cervical cancer prevention programmes in high HIV prevalence settings.

12 October 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
MMMaphe Mthembu
Maphe Mthembu
KBKathryn A Bowman
Kathryn A Bowman
LDLeela Rl Davies
Leela Rl Davies
SKSharon Khuzwayo
Sharon Khuzwayo
LMLusanda Mazibuko
Lusanda Mazibuko
EWEmily B Wong
Emily B Wong
Summary: Background: Tuberculosis (TB) is a leading infectious cause of death worldwide and treating latent TB infection (LTBI) with TB preventative therapy is a global priority. This study aimed to measure interferon gamma (IFN-γ) release assay (IGRA) positivity (the current reference standard for LTBI diagnosis) and Mtb- specific IgG antibodies in otherwise healthy HIV-negative and HIV-positive adults. Methods: One-hundred and eighteen adults (65 HIV-negative and 53 antiretroviral-naïve HIV-positive), from a peri-urban setting in KwaZulu-Natal, South Africa were enrolled. IFN-γ release following stimulation with ESAT-6/CFP-10 peptides and plasma IgG antibodies specific for multiple Mtb antigens were measured using the QuantiFERON-TB Gold Plus (QFT) and customized Luminex assays, respectively. The relationships between QFT status and anti- Mtb IgG levels and HIV-status, sex, age and CD4 count were analyzed. Findings: Older age, male sex and higher CD4 count were independently associated with QFT positivity ( p = 0.045, 0.05 and 0.002 respectively). There was no difference in QFT status between HIV-positive and HIV-negative groups (58% and 65% respectively, p = 0.06), but within CD4 count quartiles, people with HIV had higher QFT positivity than people without HIV ( p = 0.008 (2 nd quartile), <0.0001 (3 rd quartile)). Mtb -specific IFN-γ levels were lowest, and Mtb -specific IgGs were highest in HIV-positive individuals with the lowest CD4 counts. Interpretation: These results suggest that the QFT assay underestimates LTBI among immunosuppressed people with HIV and Mtb -specific IgG may be a useful alternative biomarker for Mtb infection. Further evaluation of how Mtb -specific antibodies can be leveraged to improve LTBI diagnosis is warranted, particularly in HIV-endemic areas. Funding: The study was funded by the NIH/NIAID [K08AI118538] (EBW) and, in part, by the Africa Health Research Institute through the Wellcome [Strategic Core award: 201433/Z/16/A]. The study was also supported in part by the Strategic Health Innovation Partnerships (SHIP) Unit of the South African Medical Research Council with funds received from the South African Department of Science and Innovation as part of a bilateral research collaboration agreement with the Government of India. Other support came from the South African Research Chairs Initiative and the Victor Daitz Foundation (TN) and the Burroughs Wellcome Fund Investigators in Pathogenesis of Infectious Disease [1022002] (EBW). This research was also funded in part by the Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE) through a grant [DEL-15-006] by the Wellcome Trust and the UK Foreign, Commonwealth & Development Office, with support from the Developing Excellence in Leadership, Training and Science in Africa (DELTAS Africa) programme (TN, MM). For the purpose of open access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission. Copyrights: © 2022 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ) Research in context: Evidence before this study: Mtb -specific IFN-γ production as measured by IGRA is the current gold standard for determining latent TB infection. However, since these tests measure immunoreactivity to Mtb peptides, they are indirect measures of Mtb infection and their performance characteristics are impacted by co-infections and comorbidities that influence immune responses, including HIV. Recently, a human phenotype has been defined in people who are highly exposed to Mtb but consistently test negative for evidence of Mtb infection by IGRA and tuberculin skin test (TST). These individuals have been observed to have a unique profile of Mtb -specific antibodies when compared to the classical IGRA positive LTBI group, suggesting that Mtb -specific antibodies may identify additional people with a history of Mtb infection or exposure when compared to IGRA alone. Comparison of IGRA and Mtb-specific antibodies in people living with HIV has not previously been performed. Added value of this study: Here, we concurrently assessed Mtb -specific IFN-γ production and IgG in a cohort of 118 well-defined HIV-negative and antiretroviral naïve HIV-positive individuals from KwaZulu-Natal, South Africa, a highly TB endemic area. We found a discrepancy between Mtb -specific IFN-γ and Mtb -specific IgG levels, particularly in HIV-positive individuals with low CD4 cell counts. Notably people with the lowest CD4 counts had the highest levels of Mtb -specific IgG levels in the plasma, and the lowest levels of QTF positivity. Implications of all evidence available: IGRAs may underestimate Mtb infection status, especially in people with HIV infection or who have T cell depletion or dysfunction. Mtb -specific IgG antibodies indicate development of a B cell response to Mtb and may have promise as an alternative biomarker of TB immunoreactivity that does not depend on T cell function.